Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_assertion type Assertion NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_head.
- NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_assertion description "[In particular, the combination of EphA2 overexpression and p53 null status was associated with decreased overall patient survival and related to increased incidence of ascites and distant metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_provenance.
- NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_assertion evidence source_evidence_literature NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_provenance.
- NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_assertion SIO_000772 16969087 NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_provenance.
- NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_assertion wasDerivedFrom befree-20140225 NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_provenance.
- NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_assertion wasGeneratedBy ECO_0000203 NP165057.RAupc121_cFKhJ4LoJqT5naLVriG7gX_UiD4xmry8pAqY130_provenance.